Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
HCW Biologics Inc. (HCWB) had Return on Tangible Equity of 26.01% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.03M |
|
$-3.47M |
|
$0.02M |
|
$0.01M |
|
$4.47M |
|
$-4.44M |
|
$5.16M |
|
$0.72M |
|
$0.72M |
|
$0.72M |
|
$0.72M |
|
$0.72M |
|
$0.72M |
|
$-4.44M |
|
$-4.28M |
|
2.10M |
|
2.10M |
|
$-1.77 |
|
$-1.77 |
|
| Balance Sheet Financials | |
$2.28M |
|
$20.88M |
|
$22.24M |
|
$24.52M |
|
$21.06M |
|
-- |
|
$0.69M |
|
$21.76M |
|
$2.76M |
|
$2.76M |
|
$2.76M |
|
3.28M |
|
| Cash Flow Statement Financials | |
$-13.39M |
|
-- |
|
$10.67M |
|
$4.67M |
|
$1.95M |
|
$-2.72M |
|
$0.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.11 |
|
-- |
|
-- |
|
-- |
|
2.46 |
|
20.00% |
|
-16439.62% |
|
-16439.62% |
|
-- |
|
2662.73% |
|
-12831.67% |
|
$-13.39M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.84 |
|
107.21 |
|
26.01% |
|
|
Return on Tangible Equity |
26.01% |
2.93% |
|
26.01% |
|
$0.84 |
|
$-6.38 |
|
$-6.38 |
|